Dr Reddy's Laboratories Ltd Stock News

Dr. Reddy’s will have exclusive rights to promote and distribute the well-established Voveran range, the Calcium range and Methergine in India.

Dr Reddy''S Laboratories has entered into an exclusive sales and distribution agreement with Novartis India (NIL) for the Voveran range, the calcium range and Methergine in India.

Novartis India has signed an exclusive sales and distribution pact with Dr Reddys Laboratories for a few of its medicines

Dr Reddy''s Laboratories has entered into an exclusive sales and distribution agreement with Novartis India Ltd (NIL), a statement said on Friday. However, this will also lead to around 400 NIL employees being laid off due to role redundancies. Under the arrangement, Dr Reddy''s will have exclusive rights to promote and distribute the well-established Voveran range, the Calcium range and Methergine in India. The company will use its strengths in promotion and distribution to considerably expand its engagement with healthcare professionals with the aim of enabling access to patients in need. "We are delighted to enter into this arrangement with NIL to promote and distribute these well-established brands that are trusted by patients and healthcare professionals," Dr Reddy''s Laboratories CEO - Branded Markets (India and Emerging Markets) M V Ramana said in the statement. The company''s India business has been a strong growth driver and remains a key focus market for the drugmaker, he added.

Dr Reddy''s Laboratories has entered into an exclusive sales and distribution agreement with Novartis India Ltd (NIL), a statement said

Stocks to watch: A 0.7 percent fall in SGX-traded Nifty50 to 17,476.5 hinted at investors taking some money off the table on Friday. Key stocks to watch out for in today''s trading session are Hero MotoCorp, Dr Reddy''s, Zomato, Tata Chemicals and Trent. Here is a list of today''s stocks to watch:

Stocks in focus: Aurobindo Pharma, Dr Reddy''s Labs, Tata Steel and more

Dr Reddy''s Laboratories on Wednesday said it has launched a vasopressin injection, which is used to control frequent urination, increased thirst, and loss of water caused by diabetes, in the American…

Dr Reddy''s Laboratories said it has launched vasopressin injection, which is used to control frequent urination, increased thirst, and loss of water caused by diabetes, in the American market.

Dr Reddy''s Laboratories, marketing partner of the Russian Direct Investment Fund for the Sputnik V and Sputnik Light vaccines, has sought government approval for use of Sputnik Light as a booster shot

Mumbai, February 8 Equity benchmark Sensex surged over 150 points in opening trade on Tuesday, tracking gains in index majors Maruti, Titan and Bajaj Finserv amid a mixed trend in global markets. Starting on a positive note, the BSE gauge was trading 156.46 points or 0.27 per cent higher at 57,777.65 in early trade. The Nifty surged 48.75 points or 0.28 per cent to 17,262.35. Maruti was the top gainer in the Sensex pack, climbing 1.83 per cent, followed by Titan, Bajaj Finserv, Bajaj Finance, Dr Reddy''s, Tata Steel and Asian Paints. On the other hand, PowerGrid, TCS, SBI, NTPC and Infosys were among the losers. In the previous session, the 30-share index ended 1,023.63 points or 1.75 per cent lower at 57,621.19. Similarly, the NSE Nifty slumped 302.70 points or 1.73 per cent to 17,213.60. Elsewhere in Asia, bourses in Hong Kong and Shanghai were trading with losses in mid-session deals, while Seoul and Tokyo were in the green. Stock exchanges in the US closed on a mixed note in the overnight session.

New Delhi: The single-dose Russian-origin Sputnik-Light vaccine has been approved for emergency use by the Indian pharma regulator, offering medics with yet another vaccination to combat the Covid-19 pandemic, which has claimed the lives of over five lakh Indians in the last two years. "In India, the Drugs Controller General has approved single-dose Sputnik Light Covid-19 vaccination emergency use approval. This is the country''s ninth Covid-19 vaccination. On Sunday, Union Health Minister Mansukh Mandaviya tweeted, "This will further boost the nation''s joint struggle against the pandemic." The single-dose Russian-origin Sputnik-Light vaccine has been certified for emergency use by the Indian pharma regulator, offering medics with yet another vaccination to combat the Covid-19 pandemic, which has claimed the lives of over five lakh Indians in the last two years. "In India, the Drugs Controller General has approved single-dose Sputnik Light Covid-19 vaccination emergency use approval. This is the country''s ninth Covid-19 vaccination.

Equity benchmark Sensex fell 225 points in opening trade on Monday, tracking losses in index majors HDFC twins, Infosys and Maruti amid persistent foreign

The week will see investors reacting to the RBI policy outcome on Thursday, its commentary on inflation, IIP reading, quarterly earnings and trends in the bond market.

Dr Reddy''s Laboratories jumped 5.74% to Rs 4,600 after the company announced that the Drugs Controller General of India (DCGI) has granted approval to the single-shot Sputnik Light vaccine for restricted use in emergency situation in India.